CD274 and non-small cell lung carcinoma: Recently, a study investigating the effect of PD-L1 expression on the survival rate of 877 non-small cell lung cancer (NSCLC) patients demonstrated that PD-L1 overexpression directly correlates with poor survival due to increased proliferation and survival of tumorigenic lung cells by preventing T-cell-mediated immune responses [22].